(Q47614726)

4 February 2018

title

Insulin aspart: a novel rapid-acting human insulin analogue (English)

1 reference

4 February 2018

1 reference

Gammeltoft S

1

1 reference

4 February 2018

Hansen BF

2

1 reference

4 February 2018

Dideriksen L

3

1 reference

4 February 2018

Lindholm A

4

1 reference

4 February 2018

Schäffer L

5

1 reference

4 February 2018

Trüb T

6

1 reference

4 February 2018

Dayan A

7

1 reference

4 February 2018

Kurtzhals P

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

4 February 2018

Expert Opinion on Investigational Drugs

published in

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

issue

9

1 reference

4 February 2018

page(s)

1431-1442

1 reference

4 February 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Monomeric insulins and their experimental and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Insulin analogs with improved pharmacokinetic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Altering the association properties of insulin by amino acid replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Receptor-binding region of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Spontaneous tumors in control F344 and charles river-CD rats and Charles River CD-1 and B6C3HF1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Limitations of the mcf-7 cell proliferation assay for detecting xenobiotic oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Insulin glargine: the first clinically useful extended-acting insulin in half a century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Monomeric insulins obtained by protein engineering and their medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.9.1431

10.1517/13543784.8.9.1431

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018